Dr. Otto Roelen

25.09.2013 • News

Oxea Celebrates 75 Years of Oxo Synthesis

On September 20, 1938, the German chemist, Dr. Otto Roelen, then the research director at Ruhrchemie in Oberhausen (now Oxea), filed a patent application for the oxo synthesis.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.